Patents granted to Japan Tobacco
Specific Patent Information
| Patent Number | Title, Independent Claims and Summary of Claims | Assignee | ||
|---|---|---|---|---|
US 5591616
|
Title – Method of transforming monocotyledon
The patent discloses that “the term ‘dedifferentiated tissue’ …means a callus or an adventitious embryo-like tissue obtained by culturing an explant in a medium containing a plant growth regulator such as an auxin or a cytokinin.” |
Japan Tobacco |
||
US 7060876
|
Title – Method for transforming monocotyledons
Granted US 7060876 is a continuation of US 08/668464 (now abandoned), which is a continuation-in-part of now granted US 5591616. The claims are generally drawn towards:
Granted US 7060876 and US 5591616 together cover the whole duration of the dedifferentiation period of monocot plant tissue that can be used as transformation material by Agrobacterium in the United States. The term “less than seven days” in the application US 2002/0178463 has been changed to “one to six days”, and there is no limit on the type of plasmid that is contained in the Agrobacterium that is used to transform the monocot plant in granted US 7060876. |
|||
US 2002/0178463
|
Title – Method of transforming monocotyledons
United States patent application US 2002/0178463 is a continuation-in-part of application US 08/193,058 (now patent US 5,591,616, see above). The content of this application is very similar to the parent application. The main difference in the claims is that independent Claim 1 recites the use of a superbinary vector having the virulence region of a defined Ti plasmid and contained in a specific strain of Agrobacterium tumefaciens and tissue is cultured in dedifferentiating medium for less than 7 days. In claim 13, the explant is derived from an immature tissue. The application discloses that the “term ‘immature’ means that the tissue has not reached the matured state of the tissue and will mature under conditions which allow the maturation.” The description doesn’t clarify what physiological or phenotypic properties an immature tissue has but merely basically restates that “immature” means not mature. |
|||
AU 667939 B
|
Title – Method of transforming monocotyledon The lead claim in the Australian patent AU 667939 B is broader than in the United States patent.In the Australian patent, a dedifferentiating or dedifferentiated tissue of a monocot is also used as the initial tissue for transformation, but there is no restriction with respect to a minimum number of days of culture in the medium to induce dedifferentiation.
|
|||
EP 604662 A1
|
Title – Method of transforming monocotyledon
The claims submitted in the European application EP 604 662 A1 are the same as the claims of the Australian patent. |
|||
| Remarks | National phase entry of PCT application WO 94/0977 in Canada (CA 2121545) is still pending. |
Note: Patent information on this page was last updated on 3 February 2006.
